Public Sector Pension Investment Board boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 26.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 628,578 shares of the healthcare conglomerate's stock after purchasing an additional 130,382 shares during the quarter. Public Sector Pension Investment Board owned about 0.07% of UnitedHealth Group worth $237,848,000 as of its most recent filing with the SEC.
A number of other large investors also recently bought and sold shares of UNH. FreeGulliver LLC raised its holdings in shares of UnitedHealth Group by 12.4% in the 3rd quarter. FreeGulliver LLC now owns 615 shares of the healthcare conglomerate's stock worth $226,000 after purchasing an additional 68 shares during the period. Global Retirement Partners LLC grew its holdings in shares of UnitedHealth Group by 32.3% during the 3rd quarter. Global Retirement Partners LLC now owns 31,367 shares of the healthcare conglomerate's stock worth $11,514,000 after purchasing an additional 7,665 shares during the period. BCGM Wealth Management LLC increased its position in UnitedHealth Group by 8.5% during the 3rd quarter. BCGM Wealth Management LLC now owns 8,710 shares of the healthcare conglomerate's stock worth $3,197,000 after purchasing an additional 683 shares in the last quarter. Rollins Financial Advisors LLC raised its holdings in UnitedHealth Group by 8.2% in the third quarter. Rollins Financial Advisors LLC now owns 1,666 shares of the healthcare conglomerate's stock valued at $612,000 after buying an additional 126 shares during the period. Finally, Impax Asset Management Group plc purchased a new position in UnitedHealth Group in the third quarter valued at approximately $1,904,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have issued reports on the stock. Stephens set a $500.00 price objective on shares of UnitedHealth Group in a research note on Friday, October 16th. Zacks Research downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 14th. Robert W. Baird decreased their price target on shares of UnitedHealth Group from $453.00 to $427.00 and set a "neutral" rating for the company in a research report on Wednesday, October 14th. UBS Group reiterated an "outperform" rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Finally, Mizuho raised their price objective on UnitedHealth Group from $493.00 to $500.00 and gave the company an "outperform" rating in a research report on Thursday, October 22nd. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $463.93.
Check Out Our Latest Report on UnitedHealth Group
Insider Buying and Selling
In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.19% of the stock is owned by corporate insiders.
UnitedHealth Group Stock Down 5.5%
NYSE UNH opened at $389.45 on Wednesday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The business has a 50 day moving average price of $391.42 and a two-hundred day moving average price of $366.73. The stock has a market cap of $348.96 billion, a PE ratio of 22.24, a P/E/G ratio of 1.49 and a beta of 0.51.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the firm posted $2.59 earnings per share. The business's quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be paid a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 annualized dividend and a yield of 2.4%. UnitedHealth Group's payout ratio is 53.00%.
Latest UnitedHealth Group News
Here's some of the latest news about UNH:
- Neutral Sentiment: A report says Meridiem Capital Partners sold its UnitedHealth shares in the third quarter. This is a limited, backward-looking signal from one fund, rather than evidence of a broad investor retreat. Read article
- Negative Sentiment: Sen. Elizabeth Warren called for breaking up major healthcare conglomerates, while coverage also cited a Senate breakup bill. The prospect of structural changes adds policy uncertainty for UnitedHealth and contributed to selling pressure. Read article
- Negative Sentiment: UnitedHealth’s weakness also weighed on healthcare funds with significant exposure to the company, potentially amplifying the impact of the stock’s decline. Read article
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.